Previous Close | 0.1850 |
Open | 0.1800 |
Bid | 0.1850 x 0 |
Ask | 0.1950 x 0 |
Day's Range | 0.1800 - 0.1950 |
52 Week Range | 0.1300 - 0.5700 |
Volume | |
Avg. Volume | 73,904 |
Market Cap | 13.547M |
Beta (5Y Monthly) | 0.04 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0370 |
Earnings Date | Jul 13, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1.00 |
BROSSARD, Quebec, July 27, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is proud to continue its expansion in Canada with the kick-off of its services in endocrinology clinics with distribution partner Labtician Ophthalmics. DIAGNOS is announcing the kick-off by Labtician Ophthalmics (“Labtician”) of
BROSSARD, Quebec, June 23, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the start of the deployment of its pathology detection systems in the retail clinics of Farmacias Benavides, a member of Walgreens Boots Alliance. “Following the signing of the agreement between DIAGNOS and
BROSSARD, Quebec, June 07, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the deployment of its Age-Related Macular Degeneration detection application into the optometry clinics of IRIS The Visual Group. It is with great pleasure that DIAGNOS is announcing the deployment of its Ag